Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06085937
PHASE1

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

Sponsor: Lindsay Maguire, MD

View on ClinicalTrials.gov

Summary

There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.

Official title: Feasibility and Safety of Single Dose Ketamine for Acutely Suicidal Patients in the Emergency Department

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2024-05-01

Completion Date

2026-04

Last Updated

2025-07-10

Healthy Volunteers

No

Interventions

DRUG

Ketamine

Patients will receive 0.2mg/kg of IV ketamine

Locations (2)

University of Kansas Strawberry Hill Campus

Kansas City, Kansas, United States

University of Kansas Medical Center Emergency Department

Kansas City, Kansas, United States